Related Experiment Video

Updated: Aug 6, 2026

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

[Medical prescriptions in haemodialysis patients: critical analysis]

Evelyne Riemer1, Estelle Werling, Marc Kribs

  • 1Service de pharmacie, centre hospitalier de Haguenau, France.

Nephrologie & Therapeutique
|August 10, 2006
PubMed

Insights

Prescriptions for chronic haemodialysis patients often deviate from legal standards, with frequent medication errors and drug interactions. This highlights the need for closer pharmaceutical monitoring in this vulnerable patient group.

Area of Science:

  • Nephrology
  • Clinical Pharmacy
  • Pharmacovigilance

Context:

  • Chronic haemodialysis patients are often prescribed multiple medications.
  • Prescribing practices in this population may not align with legal and recommended guidelines.
  • A lack of specific drug studies for haemodialysis patients contributes to prescribing challenges.

Purpose:

  • To analyze the adherence of haemodialysis patient prescriptions to legal registrations.
  • To evaluate the accuracy of drug use and identify potential drug-drug interactions.
  • To assess the implications of current prescribing practices for patient safety and clinical responsibility.

Summary:

  • A study of 64 chronic haemodialysis patients revealed significant discrepancies between prescribed medications and legal/recommended guidelines.
  • Patients averaged 9.6 drugs, with 2.4 prescriptions per patient showing non-compliance and 89% having defective usage instructions.
  • A high prevalence of drug-drug interactions (78%) was observed, underscoring the complexity of medication management.

Impact:

  • Only 8% of prescriptions were fully compliant, indicating a critical gap in evidence-based prescribing for haemodialysis patients.
  • Clinicians face potential legal risks due to reliance on experience rather than established guidelines.
  • The high incidence of drug-drug interactions necessitates enhanced pharmaceutical care and monitoring to improve patient outcomes.
Abstract

Related Concept Videos

Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...